Related Experiment Video
Updated: May 5, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
From small studies to precision medicine: prioritizing candidate biomarkers
Daniel P Gaile1, Jeffrey C Miecznikowski1
1Department of Biostatistics, SUNY University of Buffalo, 433 Kimball Tower, 3435 Main Street, Buffalo, NY 14214, USA.
For biomarker discovery in precision medicine, outlying degree methods are best for identifying candidate biomarkers from small studies. These methods effectively detect patient-specific aberrant expression events in limited sample sizes.
Area of Science:
- Biostatistics
- Genomics
- Bioinformatics
Background:
- Personalized medicine and big data present challenges in biomarker development.
- Best practices for extracting candidate biomarkers from small, hypothesis-generating studies remain unclear.
Purpose of the Study:
- To compare methods for identifying patient-specific aberrant gene expression events in small- to medium-sized studies.
- To determine the optimal approach for biomarker discovery in the context of precision medicine.
Main Methods:
- Evaluation of various data-analytic methods for detecting aberrant expression.
- Focus on outlying degree methods for identifying significant expression events.
- Analysis of studies with sample sizes ranging from 10 to 50.
Main Results:
- Outlying degree methods demonstrated superior performance in detecting patient-specific aberrant expression events.
- These methods proved effective even with limited sample sizes (10-50 samples).
- The findings support the utility of outlying degree methods for hypothesis-generating biomarker studies.
Conclusions:
- Outlying degree methods represent a best practice for biomarker discovery in small-scale studies.
- These methods are crucial for advancing personalized medicine by identifying relevant biomarkers.
- Further research should leverage these techniques for robust biomarker development.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...